<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Randhawa AS</submitter><funding>NINDS NIH HHS</funding><pagination>2426-2434</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9329219</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>53(8)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>To emphasize treatment speed for time-sensitive conditions, emergency medicine has developed not only the concept of the golden hour, but also the platinum half-hour. Patients with acute stroke treated within the first half-hour of onset have not been previously characterized.&lt;h4>Methods&lt;/h4>In this cohort study, we analyzed patients enrolled in the FAST-MAG (Field Administration of Stroke Therapy-Magnesium) trial, testing paramedic prehospital start of neuroprotective agent ≤2 hours of onset. The features of all acute cerebral ischemia, and intracranial hemorrhage patients with treatment starting at ≤30 m of last known well were compared with later-treated patients.&lt;h4>Results&lt;/h4>Among 1680 patients, 203 (12.1%) received study agents within 30 minutes of last known wel</pubmed_abstract><journal>Stroke</journal><pubmed_title>Beyond the Golden Hour: Treating Acute Stroke in the Platinum 30 Minutes.</pubmed_title><pmcid>PMC9329219</pmcid><funding_grant_id>U01 NS044364</funding_grant_id><pubmed_authors>Valdes-Sueiras M</pubmed_authors><pubmed_authors>Restrepo-Jimenez L</pubmed_authors><pubmed_authors>Conwit R</pubmed_authors><pubmed_authors>Hamilton S</pubmed_authors><pubmed_authors>Villablanca P</pubmed_authors><pubmed_authors>Pariona-Vargas F</pubmed_authors><pubmed_authors>Gornbein J</pubmed_authors><pubmed_authors>Sharma L</pubmed_authors><pubmed_authors>Randhawa AS</pubmed_authors><pubmed_authors>Saver JL</pubmed_authors><pubmed_authors>Sanossian N</pubmed_authors><pubmed_authors>Liebeskind DS</pubmed_authors><pubmed_authors>Kim-Tenser M</pubmed_authors><pubmed_authors>Starkman S</pubmed_authors><pubmed_authors>Avila G</pubmed_authors><pubmed_authors>Stratton S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Beyond the Golden Hour: Treating Acute Stroke in the Platinum 30 Minutes.</name><description>&lt;h4>Background&lt;/h4>To emphasize treatment speed for time-sensitive conditions, emergency medicine has developed not only the concept of the golden hour, but also the platinum half-hour. Patients with acute stroke treated within the first half-hour of onset have not been previously characterized.&lt;h4>Methods&lt;/h4>In this cohort study, we analyzed patients enrolled in the FAST-MAG (Field Administration of Stroke Therapy-Magnesium) trial, testing paramedic prehospital start of neuroprotective agent ≤2 hours of onset. The features of all acute cerebral ischemia, and intracranial hemorrhage patients with treatment starting at ≤30 m of last known well were compared with later-treated patients.&lt;h4>Results&lt;/h4>Among 1680 patients, 203 (12.1%) received study agents within 30 minutes of last known wel</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T20:06:55.677Z</modification><creation>2025-04-04T20:06:55.677Z</creation></dates><accession>S-EPMC9329219</accession><cross_references><pubmed>35545939</pubmed><doi>10.1161/STROKEAHA.121.036993</doi><doi>10.1161/strokeaha.121.036993</doi></cross_references></HashMap>